Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (521-530 of 681) with videos related to

Pageof 69
Sort By:
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupP Sudre, B J Hirschel, J M Gatell, et al.
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Scandinavian Journal of Infectious Diseases|February 11, 2011
Factors associated with the development of cytomegalovirus infection following solid organ transplantationCaspar da Cunha-Bang, Søren S Sørensen, Martin Iversen, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
Journal of the International AIDS Society|October 20, 2012
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyKathy Petoumenos, Signe W Worm, Eric Fontas, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Pageof 69

Showing results (521-530 of 681) with videos related to

Sort By:
Pageof 69
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupP Sudre, B J Hirschel, J M Gatell, et al.
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Scandinavian Journal of Infectious Diseases|February 11, 2011
Factors associated with the development of cytomegalovirus infection following solid organ transplantationCaspar da Cunha-Bang, Søren S Sørensen, Martin Iversen, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
Journal of the International AIDS Society|October 20, 2012
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyKathy Petoumenos, Signe W Worm, Eric Fontas, et al.
Journal of the International AIDS Society|March 7, 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D StudyCamilla I Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Pageof 69